Convolvulus Arvensis Health Benefits
Convolvulus arvensis health benefits include anticancer properties. Also known as bindweed, the convolvulus arvensis is a flowering plant that has been studied for its use in fighting cancer.
Convolvulus arvensis belongs to the bindweed family Convolvulaceae and is perhaps better known as a morning glory. About 250 species of flowering plants belong to the bindweed family. One of them in particular, Convolvulus arvensis, has been the subject of at least one scientific study to evaluate its use in fighting cancer.
To help identify convolvulus arvensis health benefits, researchers extracted components from the plant. These agents were composed primarily of proteins and polysaccharides. The extract was used to determine its effect on fibrosarcoma growth in mice and angiogenesis (the growth of capillaries and other blood vessels that nourish tumors) in chick embryos. In addition, the scientists tested the impact of the extract on lymphocytes (white blood cells that fight infection) in test tubes and in tumor cell growth in animals.
The researchers found that convolvulus arvensis health benefits included an ability to inhibit tumor growth in the mice by about 70 percent. Convolvulus arvensis extract also interfered with angiogenesis in chick embryos and improved survival of lymphocytes. However, the flower extract did not kill tumor cells in culture. Based on these findings, the authors of the study noted that convolvulus arvensis health benefits concerning anti-cancer properties deserved further study. (Meng 2002)
To our knowledge, however, no other scientific studies have been published regarding the impact of convolvulus arvensis on cancer. Other possible convolvulus arvensis health benefits may include its use as a diuretic and a laxative. However, no one should use a convolvulus arvensis supplement without first consulting a knowledgeable healthcare provider.
Meng XL et al. Effects of a high molecular mass Convolvulus arvensis extract on tumor growth and angiogenesis. Puerto Rico Health Sciences Journal 2002 Dec; 21(4): 323-28